• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Relapsing-remitting multiple sclerosis arising in a patient with atopic dermatitis on dupilumab.

作者信息

Laageide Leah, Verhave Brendon, Samkoff Lawrence, Looney Richard, Beck Lisa

机构信息

Department of Dermatology, University of Rochester Medical Center, Rochester, New York.

Department of Neurology, University of Rochester Medical Center, Rochester, New York.

出版信息

JAAD Case Rep. 2021 Jul 15;15:33-35. doi: 10.1016/j.jdcr.2021.07.003. eCollection 2021 Sep.

DOI:10.1016/j.jdcr.2021.07.003
PMID:34401425
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8349746/
Abstract
摘要

相似文献

1
Relapsing-remitting multiple sclerosis arising in a patient with atopic dermatitis on dupilumab.在使用度普利尤单抗治疗特应性皮炎的患者中出现复发缓解型多发性硬化症。
JAAD Case Rep. 2021 Jul 15;15:33-35. doi: 10.1016/j.jdcr.2021.07.003. eCollection 2021 Sep.
2
A rapid flow cytometric assay to detect CD4+ and CD8+ T-helper (Th) 0, Th1 and Th2 cells in whole blood and its application to study cytokine levels in atopic dermatitis before and after cyclosporin therapy.一种用于检测全血中CD4+和CD8+ T辅助（Th）0、Th1及Th2细胞的快速流式细胞术检测方法及其在研究环孢素治疗前后特应性皮炎细胞因子水平中的应用。
Br J Dermatol. 2001 Jan;144(1):24-33. doi: 10.1046/j.1365-2133.2001.03948.x.
3
Rosacea associated with dupilumab therapy.与度普利尤单抗治疗相关的酒渣鼻。
J Dermatolog Treat. 2021 Feb;32(1):114-116. doi: 10.1080/09546634.2019.1624683. Epub 2019 Jun 9.
4
Dupilumab Effects on Innate Lymphoid Cell and Helper T Cell Populations in Patients with Atopic Dermatitis.度普利尤单抗对特应性皮炎患者先天性淋巴细胞和辅助性T细胞群体的影响。
JID Innov. 2021 Feb 20;1(1):100003. doi: 10.1016/j.xjidi.2021.100003. eCollection 2021 Mar.
5
Dupilumab: A review of its use in the treatment of atopic dermatitis.度普利尤单抗：治疗特应性皮炎的研究进展。
J Am Acad Dermatol. 2018 Mar;78(3 Suppl 1):S28-S36. doi: 10.1016/j.jaad.2017.12.022.
6
In vitro responsiveness to IL-18 in combination with IL-12 or IL-2 by PBMC from patients with bronchial asthma and atopic dermatitis.支气管哮喘和特应性皮炎患者外周血单个核细胞对白细胞介素-18联合白细胞介素-12或白细胞介素-2的体外反应性。
Clin Immunol. 2004 Apr;111(1):61-8. doi: 10.1016/j.clim.2003.12.006.
7
Drug evaluation review: dupilumab in atopic dermatitis.药物评估综述：度普利尤单抗治疗特应性皮炎
Immunotherapy. 2015;7(10):1043-58. doi: 10.2217/imt.15.69.
8
Dupilumab-related type 1 diabetes in a patient with atopic dermatitis: a case report.一名特应性皮炎患者中与度普利尤单抗相关的1型糖尿病：病例报告
Diabetol Int. 2021 Aug 10;13(1):300-303. doi: 10.1007/s13340-021-00526-1. eCollection 2022 Jan.
9
Biphasic cytokine expression by T cell clones from patients with atopic dermatitis with different incubation periods and strengths of stimuli.来自不同潜伏期和刺激强度的特应性皮炎患者的T细胞克隆的双相细胞因子表达。
Fukushima J Med Sci. 2001 Dec;47(2):51-62. doi: 10.5387/fms.47.51.
10
Remission of Alopecia Universalis after 1 Year of Treatment with Dupilumab in a Patient with Severe Atopic Dermatitis.度普利尤单抗治疗1年后，重度特应性皮炎患者泛发性斑秃缓解
Skin Appendage Disord. 2022 Jan;8(1):38-41. doi: 10.1159/000517832. Epub 2021 Jul 27.

引用本文的文献

1
Dupilumab, a Novel Treatment for Peripheral Neuropathy: A Case Series.度普利尤单抗治疗周围神经病变的病例系列：一项新疗法
Dermatol Ther (Heidelb). 2025 Jun;15(6):1569-1577. doi: 10.1007/s13555-025-01415-0. Epub 2025 Apr 24.
2
Two-sample Mendelian randomization analysis of causal relationship between eczema and autoimmune diseases.两样本孟德尔随机化分析湿疹与自身免疫性疾病之间的因果关系。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Jun 28;49(6):932-942. doi: 10.11817/j.issn.1672-7347.2024.240103.
3
Ellagic acid effects on disease severity, levels of cytokines and T-bet, RORγt, and GATA3 genes expression in multiple sclerosis patients: a multicentral-triple blind randomized clinical trial.

本文引用的文献

1
De novo psoriasis in atopic dermatitis patients treated with dupilumab: a retrospective cohort.接受度普利尤单抗治疗的特应性皮炎患者新发银屑病：一项回顾性队列研究
J Eur Acad Dermatol Venereol. 2021 Apr;35(4):e296-e297. doi: 10.1111/jdv.17050. Epub 2020 Dec 10.
2
The immune signatures of multiple sclerosis: Lessons from twin studies.
Proc Natl Acad Sci U S A. 2020 Sep 29;117(39):24013-24015. doi: 10.1073/pnas.2016711117. Epub 2020 Sep 14.
3
IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic Dermatitis.度普利尤单抗阻断白介素-4 受体α可减少特应性皮炎金黄色葡萄球菌定植并增加微生物多样性。
鞣花酸对多发性硬化症患者疾病严重程度、细胞因子水平以及T-bet、RORγt和GATA3基因表达的影响：一项多中心三盲随机临床试验
Front Nutr. 2023 Sep 19;10:1238846. doi: 10.3389/fnut.2023.1238846. eCollection 2023.
4
Effect of Dupilumab on Generalized Verrucosis in Refractory Bullous Pemphigoid.度普利尤单抗对难治性大疱性类天疱疮泛发性疣状病变的影响
Acta Derm Venereol. 2023 Sep 14;103:adv12324. doi: 10.2340/actadv.v103.12324.
5
Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis.度普利尤单抗用于中重度特应性皮炎和多发性硬化症患者。
JAAD Case Rep. 2022 Nov 5;31:1-5. doi: 10.1016/j.jdcr.2022.10.031. eCollection 2023 Jan.
6
Onset of multiple sclerosis in a patient on dupilumab therapy for atopic dermatitis: A case report.一名接受度普利尤单抗治疗特应性皮炎的患者发生多发性硬化症：病例报告。
Dermatol Ther. 2022 Oct;35(10):e15740. doi: 10.1111/dth.15740. Epub 2022 Aug 8.
J Invest Dermatol. 2020 Jan;140(1):191-202.e7. doi: 10.1016/j.jid.2019.05.024. Epub 2019 Jun 25.
4
Dupilumab, A Monoclonal Antibody for Atopic Dermatitis: A Review of Current Literature.度普利尤单抗，一种用于特应性皮炎的单克隆抗体：当前文献综述
Skin Therapy Lett. 2016 Mar;21(2):1-5.
5
IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells.白细胞介素-4通过选择性沉默抗原呈递细胞中的白细胞介素-23来消除辅助性T细胞17介导的炎症。
Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):2163-8. doi: 10.1073/pnas.1416922112. Epub 2015 Feb 2.
6
Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.度普利尤单抗治疗中重度特应性皮炎成人患者。
N Engl J Med. 2014 Jul 10;371(2):130-9. doi: 10.1056/NEJMoa1314768.
7
T helper cells plasticity in inflammation.辅助性 T 细胞在炎症中的可塑性。
Cytometry A. 2014 Jan;85(1):36-42. doi: 10.1002/cyto.a.22348. Epub 2013 Sep 5.
8
A polymorphism in the interleukin-4 receptor affects the ability of interleukin-4 to regulate Th17 cells: a possible immunoregulatory mechanism for genetic control of the severity of rheumatoid arthritis.白细胞介素-4 受体中的一种多态性影响白细胞介素-4 调节 Th17 细胞的能力：遗传控制类风湿关节炎严重程度的可能免疫调节机制。
Arthritis Res Ther. 2011 Feb 4;13(1):R15. doi: 10.1186/ar3239.
9
Allergy and multiple sclerosis: a population-based case-control study.过敏与多发性硬化症：一项基于人群的病例对照研究。
Mult Scler. 2009 Aug;15(8):899-906. doi: 10.1177/1352458509106211.
10
Human Th17 cells.人类辅助性T细胞17
Arthritis Res Ther. 2008;10(2):206. doi: 10.1186/ar2392. Epub 2008 Apr 18.